What is the name of Trastuzumab injection (subcutaneous injection) (Herceptin Hylecta)?

Trastuzumab injection (subcutaneous injection ) (Herceptin Hylecta) is usually sold under the trade name Herceptin Hylecta. Common names include Trastuzumab injection, trastuzumab and hyaluronidase-oysk, trastuzumab hyaluronidase,it contains the active ingredient trastuzumaband belongs to a group of drugs called antineoplastic (or anticancer) agents. There are many different classes of anti-tumor drugs currently available.

Trastuzumab injection (subcutaneous injection) belongs to a class of drugs called monoclonal antibodies, which are proteins made in a laboratory. These proteins are designed to recognize and bind to other unique proteins in the body. Trastuzumab injection (subcutaneous) selectively binds to a protein called human epidermal growth factor receptor 2 (HER2). HER2 is present in large amounts on the surface of some cancer cells. When trastuzumab injection (subcutaneously) binds to the HER2 receptor, it blocks the growth and spread of cancer cells. Trastuzumab injection (subcutaneous injection) is used to treat breast cancer that tests positive for HER2, and is also used alone or in combination with other drugs to treat breast cancer, such as aromatase inhibitors (hormone receptor-positive breast cancer) or taxanes (such as paclitaxel or docetaxel).

It is understood that the original drug of trastuzumab injection (subcutaneous injection) has been launched in China, but the specific price and other relevant information are not yet clear. Since the drug has been on the market for a short time, it has not been included in the scope of medical insurance. At present, there are no generic drugs of Trastuzumab injection (subcutaneous injection) produced and marketed. For more information and specific prices of Trastuzumab injection (subcutaneous injection), please consult a medical consultant.